Liquidity and going-concern pressure
The company has recurring operating losses and limited cash, so it may need additional financing to sustain commercialization and operations.
- Scope
- Corporate-wide
- Materiality
- high
Catheter Precision, Inc.
Catheter Precision, Inc. develops and commercializes medical devices for cardiac electrophysiology and wound closure. Its current business is centered on two products: the VIVO System, which helps localize the origin of idiopathic ventricular arrhythmias, and LockeT, a suture retention device used to support wound healing. The company also has a history of technology development outside its current focus, including prior work on an excimer laser platform and more recently intellectual property related to cardiac-device interfacing. Catheter Precision sells through distributors and direct international relationships, with a meaningful portion of sales coming from outside the United States. The business remains early-stage and capital constrained, with recurring operating losses and a focus on product commercialization and regulatory expansion.
−2 323,3 %
92,3 %
−2 098,0 %
+95,0 %
0.10
0.08
| % | |
|---|---|
| Cardiac electrophysiology mapping | 60% 3D mapping and localization tools used by electrophysiologists to identify arrhythmia origin sites before procedures. |
| Surgical wound closure support | 30% Suture retention devices used to distribute tension and support wound healing during closure. |
| Software and service upgrades | 5% Optional software upgrades and related support services sold with the VIVO System. |
| International distribution and regulatory commercialization | 5% Commercial activity tied to distributor channels, CE Mark expansion, and market access work. |
The company sells primarily to hospitals, electrophysiology labs, and clinicians treating cardiac arrhythmias, where...
- Electrophysiology physicians and EP labsprimary
Buy the VIVO System to help localize idiopathic ventricular arrhythmia origin sites before procedures.
- Hospitals and surgical cliniciansprimary
Buy LockeT for wound closure support and to help distribute suture tension over a larger area.
- Independent medical device distributorssecondary
Purchase and resell products in international markets, helping the company reach customers without a large direct sales force.
- International healthcare providerssecondary
Buy CE Mark-cleared products where local regulatory approval is required before commercialization.
Catheter Precision is headquartered in the United States, where it also records a majority of its sales...
- •United States is the core revenue base and operating center
- •Europe and the UK are early international commercialization markets
- •CE Mark clearance expands access across the EU and EFTA countries
- •Middle East distribution agreement supports non-U.S. growth for LockeT
- •China patent issuance supports longer-term IP positioning
Catheter Precision's near-term strategy is to convert regulatory approvals into commercial adoption for both VIVO and...
01
Expand international commercializationshort-term
The company needs broader market access and distributor reach to scale sales without a large direct commercial infrastructure.
02
Support product adoption with clinical evidenceshort-term
Clinical data helps justify use, strengthen marketing claims, and potentially expand indications with regulators and clinicians.
03
Protect and reorganize intellectual propertymedium-term
IP ownership and patent coverage support long-term commercialization options and may create value outside the current operating plan.
Catheter Precision faces the risks typical of an early-stage medical device company: limited cash, recurring losses,...
Regulatory and market-access delays
Sales depend on FDA and CE Mark clearances and on local market access, so delays can directly reduce revenue opportunities.
- Scope
- VIVO System and LockeT international expansion
- Materiality
- high
Commercial adoption risk
Clinicians and hospitals must adopt new devices based on workflow, evidence, and reimbursement considerations, which can slow uptake.
- Scope
- VIVO System and LockeT
- Materiality
- high
Distributor concentration and execution risk
A meaningful part of international growth relies on independent distributors, which can limit control over pricing, promotion, and inventory.
- Scope
- Europe, UK, Middle East, other export markets
- Materiality
- medium
Product liability and quality risk
Medical devices can face claims, recalls, or compliance issues if performance or manufacturing quality is inadequate.
- Scope
- All marketed products
- Materiality
- medium
Revenue recognition timing
Reported revenue and gross margin timing
Long-lived asset and intangible impairment
Operating results and balance sheet carrying values
Stock-based compensation
Operating loss and diluted share count
Income tax valuation allowance
Tax benefit/expense and equity
: 28.4.2026